In 2012, C.R. Bard faced its first transvaginal mesh lawsuit. The trial took place in a California court, and resulted in the jury deciding to award the plaintiff $5.5 million. C.R. Bard appealed the ruling, and in late November 2014, a California appeals court upheld the majority of the 2012 verdict.
Though the jury called for a $5.5 million award, the portion of the plaintiff’s award for which C.R. Bard was responsible was minimized to $3.6 million. This latter figure the appeals court upheld in the November ruling.
The California case involved a woman who received the C.R. Bard Avaulta mesh implant to treat pelvic organ prolapse (POP). The woman filed her lawsuit against C.R. Bard after sustaining serious injuries from the defective Avaulta implant.
As the appeals process in this California case did not turn out in C.R. Bard’s favor, perhaps the manufacturer will begin to see that losing in a trial, and appealing the verdict, is a futile strategy, especially in light of the thousands of lawsuits they face in federal and state courts across the U.S.
The defective medical device lawyers at Carey Danis & Lowe are encouraged by the appeals court’s decision to uphold the 2012 verdict. It is a confirmation that strong cases stand up in court.
With years of experience in working on cases involving defective transvaginal mesh, the dedicated team of lawyers at Carey Danis & Lowe are known for working tirelessly to recover losses for our clients in transvaginal mesh lawsuits. When you seek the legal assistance of Carey Danis & Lowe, you can rest assured that our team will build a strong case, and win you a day in court to share your story of pain and suffering.
We would like to hear from you if you have been injured by transvaginal mesh. Call Carey Danis & Lowe at 800.721.2519, or complete a confidential personal injury claim form.
Check the Carey Danis & Lowe law blog often for transvaginal mesh lawsuit updates.References: Defective Medical Device litigation, Transvaginal Mesh